FdaApplication
NDA 213135
Identifiers
- fda_app_no: NDA213135
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2020-11-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUTAB | MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE | 0.225GM;0.188GM;1.479GM | TABLET;ORAL |
1 product